Changchun Jingyou, a subsidiary of Jingyou Pharmaceutical (00858), plans to repurchase approximately 10.06% of Changchun Jingyou's shares from Changchun Handu Dingye Real Estate Planning and Sales Co., Ltd.

Zhitong Finance App News, Jingyou Pharmaceutical (00858) announced that on December 30, 2025, Changchun Jingyou (an indirect non-wholly-owned subsidiary of the company with 80.46% interest) plans to buy back about 10.06% of Changchun Jingyou's shares from Changchun Handu Dingye Real Estate Planning and Sales Co., Ltd. at a cost of RMB 4.4 million. After the share repurchase is completed, the repurchased shares will be cancelled, and the shareholders' shareholders' shareholding ratio in Changchun Jingyou will increase proportionately after the shares are cancelled, so the Group's shares in Changchun Jingyou will increase to 89.46%. Following share repurchase and share cancellation, Changchun Jingyou will continue to be an indirect non-wholly-owned subsidiary of the Group.

The board of directors believes that the share repurchase provides an appropriate opportunity for the Group to use Changchun Jingyou's own cash resources to further consolidate its control and ownership of Changchun Jingyou without affecting the normal business operations of Changchun Jingyou, and anticipates that the share repurchase will increase Changchun Jingyou's profit per share.